PMID- 37443053 OWN - NLM STAT- MEDLINE DCOM- 20230717 LR - 20230718 IS - 1477-7525 (Electronic) IS - 1477-7525 (Linking) VI - 21 IP - 1 DP - 2023 Jul 13 TI - Health-related quality of life and its associated factors among outpatients with heart failure: a cross-sectional study. PG - 73 LID - 10.1186/s12955-023-02142-w [doi] LID - 73 AB - BACKGROUND: Heart Failure (HF) is a chronic disease associated with life-limiting symptoms that could negatively impact patients' health-related quality of life (HRQOL). This study aimed to evaluate HRQOL and explore the factors associated with poor HRQOL among patients with HF in Jordan. METHODS: This cross-sectional study used the validated Arabic version of the Minnesota Living with Heart Failure Questionnaire to assess HRQOL in outpatients with HF visiting cardiology clinics at two public hospitals in Jordan. Variables were collected from medical records and custom-designed questionnaires, including socio-demographics, biomedical variables, and disease and medication characteristics. Ordinal regression analysis was used to explore variables associated with poor HRQOL among HF patients. RESULTS: Ordinal regression analysis showed that the number of HF medications (P < 0.05) and not taking a loop diuretic (P < 0.05) significantly increased HRQOL, while the number of other chronic diseases (P < 0.05), stage III/IV of HF (P < 0.01), low monthly income (P < 0.05), and being unsatisfied with the prescribed medications (P < 0.05) significantly decreased HRQOL of HF patients. CONCLUSIONS: Although the current study demonstrated low HRQOL among patients with HF in Jordan, HRQOL has a considerable opportunity for improvement in those patients. Variables identified in the present study, including low monthly income, higher New York Heart Association (NYHA) classes, a higher number of comorbidities, and/or taking a loop diuretic, should be considered in future intervention programs, aiming to improve HRQOL in patients with HF. CI - (c) 2023. The Author(s). FAU - Jarab, Anan S AU - Jarab AS AD - Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid, 22110, Jordan. AD - College of Pharmacy, Al Ain University, Abu Dhabi, UAE. FAU - Hamam, Hanan W AU - Hamam HW AD - Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid, 22110, Jordan. FAU - Al-Qerem, Walid A AU - Al-Qerem WA AD - Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, P.O. Box 130, Amman, 11733, Jordan. FAU - Heshmeh, Shrouq R Abu AU - Heshmeh SRA AD - Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid, 22110, Jordan. FAU - Mukattash, Tareq L AU - Mukattash TL AD - Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid, 22110, Jordan. FAU - Alefishat, Eman A AU - Alefishat EA AUID- ORCID: 0000-0003-4584-9166 AD - Department of Pharmacology, College of Medicine and Health Science, Khalifa University of Science and Technology, Abu Dhabi, 127788, United Arab Emirates. eman.alefishat@ku.ac.ae. AD - Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman, 11942, Jordan. eman.alefishat@ku.ac.ae. AD - Center For Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, 127788, United Arab Emirates. eman.alefishat@ku.ac.ae. LA - eng PT - Journal Article DEP - 20230713 PL - England TA - Health Qual Life Outcomes JT - Health and quality of life outcomes JID - 101153626 RN - 0 (Sodium Potassium Chloride Symporter Inhibitors) SB - IM MH - Humans MH - *Quality of Life MH - Cross-Sectional Studies MH - Outpatients MH - Sodium Potassium Chloride Symporter Inhibitors MH - *Heart Failure/complications MH - Surveys and Questionnaires MH - Chronic Disease PMC - PMC10347808 OTO - NOTNLM OT - Health-related quality of life OT - Heart failure OT - Intervention OT - Jordan OT - Minnesota living with heart failure questionnaire COIS- The authors declare no competing interests. EDAT- 2023/07/14 13:05 MHDA- 2023/07/17 06:42 PMCR- 2023/07/13 CRDT- 2023/07/13 23:30 PHST- 2022/11/22 00:00 [received] PHST- 2023/06/03 00:00 [accepted] PHST- 2023/07/17 06:42 [medline] PHST- 2023/07/14 13:05 [pubmed] PHST- 2023/07/13 23:30 [entrez] PHST- 2023/07/13 00:00 [pmc-release] AID - 10.1186/s12955-023-02142-w [pii] AID - 2142 [pii] AID - 10.1186/s12955-023-02142-w [doi] PST - epublish SO - Health Qual Life Outcomes. 2023 Jul 13;21(1):73. doi: 10.1186/s12955-023-02142-w.